Antigua PM asks US President for COVID vaccines for CARICOM
(Jamaica Gleaner) – Antigua and Barbuda’s Prime Minister Gaston Browne has written to US President Joseph Biden, requesting that CARICOM countries be included in the provision of AstraZeneca vaccines to Canada and Mexico.
Pointing out that the Caribbean is the third border of the United States, Browne argued that as the safety of the US would be imperiled if Canada and Mexico are not inoculated to achieve herd immunity, similarly the US would remain at risk if CARICOM countries are neglected.
Browne explained to Biden that the Caribbean region “is among the worst affected by the COVID-19 pandemic”. Consequently, he said, “our economies have experienced shrinkage of up to 30 per cent; unemployment has risen to over 50 per cent in some cases; poverty has expanded everywhere; and our revenues have declined precipitously, forcing us to increase debt which we have had to incur at high rates of interest”.
He asserted that “the vulnerability of states must become an important criterion in the provision of vaccines, and the Caribbean region is among the most vulnerable in the world”. Describing the economic impact of the pandemic as “overwhelming”, Browne said: “Many Caribbean countries are in danger of collapsing from a massive economic sclerosis”.
The Caribbean leader added that “If these conditions are not addressed soon, we face a crumbling of our security systems from which drug traffickers, money launderers, people traffickers, and organised crime will take advantage to the detriment of our countries and of the US. Inevitably, there will also be a surge of refugees”.
Browne implored Biden “to take account of the Caribbean – the third border of the US – in his plan to make the US safer by contributing to the safety of its neighbours. “For instance,” he said, “it would take only a few hundred thousand vaccinations to inoculate 80 per cent of the seven countries of the Organisation of Eastern Caribbean States. Reaching herd immunity would also be an excellent testing ground by which the US could judge the efficacy of herd immunity”.